Overall survival of patients with advanced colorectal cancer correlates with availability of fluorouracil, irinotecan, and oxaliplatin regardless of whether doublet or single-agent therapy is used first-line

• GROTHEY A

収録刊行物

• J Clin Oncol

  J Clin Oncol 23 9441-9442, 2005

詳細情報

• CRID: 1573950400556431360
• NII論文ID: 10030229757
• データソース種別:
  • CiNii Articles